U.S. FDA authorizd InteliSwabﾙ COVID-19 rapid tests for at-home testing for delta variant detection
On Nov. 2, 2021, OraSure Technologies announced that the EUA for its InteliSwabﾙ COVID-19 rapid tests had been amended by the Food and Drug Administration (FDA) to only require one test for individuals with symptoms of COVID-19.
Tags:
Source: OraSure Technologies
Credit:
